touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103
Create your
podcast in
minutes
It is Free